Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sona Topas Tourism Industry Tbk. (SONA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Sona Topas Tourism Industry Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Sona Topas Tourism Industry Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Sona Topas Tourism Industry Tbk. trades at Rp2,270 (market cap 1.5T, 9.7K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 7.8× Sona Topas Tourism Industry Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (429.7K versus 9.7K). Which is the better fit depends on your goals.

SONATSPC
Market Cap
1.5T11.68T
Volume
9.7K429.7K
Lot
974.3K
Turnover
21.97M1.11B
Average Price
2,264.642,591.65
Value
21.97M1.11B
Indicative Equilibrium Price
2,580
Indicative Equilibrium Volume
100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SONA
View details
TSPC
View details

About Sona Topas Tourism Industry Tbk.

PT Sona Topas Tourism Industry Tbk (the Company) was established based on notarial deed No.56 dated August 25, 1978 of Djonny Imam Soedjono for Edison Sianipar SH, under the name of PT Sona Topas Group. PT Sona Topas Tourism Industry Tbk has focused on providing tourism related services. The Company became a public listed company in July 1992 when it made an IPO and currently, all its 165,600,000 shares are traded on the JSX. The Company’s commercial operations started in 1980.

Read more on SONA

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC